— Know what they know.
Not Investment Advice

PGEN NASDAQ

Precigen, Inc.
1W: -9.3% 1M: -22.1% 3M: +9.2% YTD: +41.1% 1Y: +42.1% 3Y: +464.5% 5Y: +28.0%
$6.15
+0.11 (+1.82%)
After Hours: $6.17 (+0.02, +0.41%)
Weekly Expected Move ±9.8%
$5 $6 $6 $7 $7
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 38 · $2.2B mcap · 164M float · 3.09% daily turnover · Short 66% of daily vol
Credit Risk of going bust: higher than 53% of companies Debt: 4.3% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.04 (down 99.3%), Precigen, Inc. would be worth roughly what it owes.
Total debt $98.3M against a stock market value of $2.16B.
Distance to default 4.81 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $46.9M (short-term plus half of long-term), stock volatility 76.7%; Altman Z'' -46.02. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Balance Sheet Trends

Total Assets
$157M +7.8% ▲
5Y CAGR: -13.0%
Total Liabilities
$136M +27.1% ▲
5Y CAGR: -11.3%
Shareholders Equity
$21M -45.7% ▼
5Y CAGR: -20.8%
Cash & Investments
$98M -0.1% ▼
5Y CAGR: -0.5%
Total Debt
$5M -7.0% ▼
5Y CAGR: -51.1%
Net Debt
-$25M -4.6% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$36M$5M$8M$30M$30M
Short-Term Investments$72M$51M$55M$68M$68M
Cash & ST Investments$109M$56M$63M$98M$98M
Net Receivables$2M$14M$2M$1M$4M
Inventory$326K$287K$0$0$10M
Other Current Assets$39M$48M$4M$3M$3M
Total Current Assets$157M$118M$69M$102M$115M
Property, Plant & Equip.$19M$15M$14M$19M$18M
Goodwill & Intangibles$90M$81M$67M$24M$18M
Long-Term Investments$49M$399K$0$0$3M
Other Non-Current Assets$46M-$8M$846K$459K$908K
Total Non-Current Assets$203M$98M$82M$43M$41M
Total Assets$360M$216M$151M$145M$157M
— Liabilities —
Accounts Payable$3M$4M$2M$4M$12M
Short-Term Debt$52K$43M$0$0$1M
Deferred Revenue$1M$25K$509K$589K$0
Other Current Liabilities$21M$24M$8M$8M$24M
Total Current Liabilities$35M$79M$23M$22M$37M
Long-Term Debt$180M$0$0$0$0
Other Non-Current Liab.$4M$0$0$79M$93M
Total Non-Current Liabilities$218M$11M$10M$85M$98M
Total Liabilities$253M$90M$33M$107M$136M
— Equity —
Common Stock$0$0$0$0$0
Retained Earnings-$1.9B-$1.9B-$2.0B-$2.1B-$2.3B
Accumulated OCI$203K-$3M-$2M$12K$0
Total Stockholders Equity$107M$126M$118M$39M$21M
Total Liabilities & Equity$360M$216M$151M$145M$157M
— Key Metrics —
Total Debt$190M$51M$7M$6M$5M
Net Debt$154M$47M-$481K-$24M-$25M
Total Investments$121M$51M$55M$68M$70M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms